tryptophan has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carlsson, A; Clark, D; Fornstedt, B; Pileblad, E | 1 |
Block, F; Clement, HW; Grote, C; Sontag, KH; Wesemann, W | 1 |
Maruyama, W; Matsubara, K; Naoi, M; Ota, M; Takahashi, T | 1 |
Bezard, E; Ko, WK; Li, Q | 1 |
4 other study(ies) available for tryptophan and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Article | Year |
---|---|
Acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on dopamine metabolism in mouse and rat striatum.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 5-Hydroxytryptophan; Animals; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Mice; Pyridines; Rats; Rats, Inbred Strains; Species Specificity; Time Factors; Tryptophan; Tyrosine | 1985 |
Functional studies on monoaminergic transmitter release in parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; 5-Hydroxytryptophan; Animals; Apomorphine; Biogenic Monoamines; Dopamine; Dopamine Agents; Dopamine Antagonists; Hydroxyindoleacetic Acid; Levodopa; Male; Monoamine Oxidase Inhibitors; Parkinson Disease, Secondary; Rats; Rats, Wistar; Stereotyped Behavior; Tryptophan | 1993 |
Structural studies of condensation products of biogenic amines as inhibitors of tryptophan hydroxylase.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Biogenic Amines; Brain; Dopamine; Isoquinolines; Kinetics; Male; Rats; Rats, Wistar; Structure-Activity Relationship; Tetrahydroisoquinolines; Tryptophan; Tryptophan Hydroxylase | 1994 |
Effects of L-tryptophan on L-DOPA-induced dyskinesia in the L-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaque model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Corpus Striatum; Dopamine; Dyskinesia, Drug-Induced; Female; Levodopa; Macaca fascicularis; Motor Activity; Parkinson Disease; Tryptophan | 2014 |